HarknessMCRHarknessRDJamesDW. The effect of a protein diet on the collagen content of mice. J Physiol1958; 144: 307–13
2.
RehnMPihlajaniemiT. Identification of three n-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts—the longest form contains a novel motif homologous to rat and drosophila frizzled proteins. J Biol Chem1995; 270: 4705–11
3.
ProckopDJ. Mutations in collagen genes as a cause of connective tissue disease. N Engl J Med1992; 326: 540–6
4.
ByersPH. Disorders of collagen biosynthesis and structure. In: ScriverCRBeaudetALSlyWSValleD, eds. The Metabolic Basis Of Inherited Disease, 6th edn, Vol 2, New York: McGraw-Hill, 1989: 2805–42
5.
KaganHMSullivanKA. Lysyl oxidase: Preparation and role in elastin biosynthesis. Methods Enzymol1982; 82(A): 637–50
6.
EyreDRPazMAGallopPM. Crosslinking in collagen and elastin. Annu Rev Biochem1984; 53: 717–48
7.
OtsuboKKatzEPMechanicGLYamauchiM. Cross-linking connectivity in bone collagen fibrils: The COOH-terminal locus of free aldehyde. Biochemistry1992; 31: 396–402
8.
FujimotoDMoriguchiTIshidaTHayashiH. The structure of pyridinoline, a collagen crosslink. Biochem Biophys Res Commun1978; 84: 52–7
9.
EyreDROguchiH. The hydroxypyridinium crosslinks of skeletal collagens: Their measurement, properties and a proposed pathway of formation. Biochem Biophys Res Commun1980; 92: 403–10
10.
RobinsSPDuncanA. Cross-linking of collagen. Location of pyridinoline in bovine articular cartilage at two sites of the molecule. Biochem J1983; 215: 175–82
11.
RobinsSP. Functional properties of collagen and elastin. In: DixonJBirdH, eds. Bailliere's Clinical Rheumatology: Biochemical Aspects Of Rheumatic Diseases, 2nd edn.London: Bailliere Tindall, 1988: 1–36
12.
RobinsSP. Analysis of the crosslinking components in collagen and elastin. Methods Biochem Anal1982; 28: 329–79
BeardsworthLJEyreDRDicksonIR. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res1990; 5: 671–6
16.
HorleinDFietzekPPKuhnK. Pro-gin: The collagen propeptidase cleavage site in the α1(I) chain of dermosparatic calf skin procollagen. FEBS Lett1978; 89: 279–82
17.
PorterRRReidKBM. The biochemistry of complement. Nature1978; 275: 699–704
GasserACeladaACourvoisierBDepierreDHulmePMRinslerM. The clinical measurement of urinary total hydroxyproline excretion. Clin Chim Acta1979; 95: 487–91
20.
TeerlinkTTavenierPNetelenbosJC. Selective determination of hydroxyproline in urine by high performance liquid chromatography using pre-column derivatisation. Clin Chim Acta1989; 183: 309–16
21.
DelmasPD. Clinical use of biochemical markers of bone remodelling in osteoporosis. In: ChristiansenCOvergaardK, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990: 450–8
22.
PinnellSRFoxRKraneSM. Human collagens: Differences in glycosylated hydroxylysines in skin and bone. Biochim Biophys Acta1971; 229: 119–22
23.
KraneSMKantrowitzFGByrneMPinnellSRSingerFR. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. J Clin Invest1977; 59: 819–27
24.
SegrestJPCunninghamIW. Variations in human urinary O-hydroxylysyl glycoside levels and their relationship to collagen metabolism. J Clin Invest1979; 49: 1497–509
25.
MoroLModrickyCStagniNVitturFde BernardB. High performance liquid chromatography analysis of urinary hydroxylysline glycosides as indicators of collagen turnover. Analyst1984; 109: 1621–8
26.
DemersLM. New biochemical marker for bone disease: Is it a breakthrough?Clin Chem1992; 38: 2169–70
27.
EyreDR. Editorial: New biomarkers of bone resorption. J Clin Endocrinol Metab1992; 74: 470A-C
28.
Editorial.Pyridinium crosslinks as markers of bone resorption. Lancet1992; 340: 278–9
29.
ColwellAEastellRAssiriAMARussellRGG. Effect of diet on deoxypyridinoline excretion. In: ChristiansenCOvergaardK, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990: 590–1
30.
StonePJLuceyECSniderGLFranzblauC. Effect of diet on urinary excretion of desmosine and hydroxylysyl pyridinoline. Am J Respir Crit Care Med1994; 149: 174–7
31.
EastellRHamptonLColwellAGreenJRAssiriAMAHespR. Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. In: ChristiansenCOvergaardK, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990: 469–70
32.
DelmasPDSchlemmerAGineytsERiisBChristiansenC. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res1991; 6: 639–44
33.
FujimotoD. Isolation and characterisation of a fluorescent material in bovine achilles tendon collagen. Biochem Biophys Res Commun1977; 76: 1124–9
34.
BarberMBordoliRSElliottGJFujimotoDScottJE. The structure(s) of pyridinoline(s). Biochem Biophys Res Commun1982; 109: 1041–6
35.
OgawaTOnoTTsudaMKawanishiY. A novel fluor in insoluble collagen: A crosslinking moiety in collagen molecules. Biochem Biophys Res Commun1982; 107: 1252–7
36.
Gunja-SmithZBoucekRJ. Collagen crosslinking compounds in human urine. Biochem J1981; 197: 759–62
37.
RobinsSP. Cross-linking of collagen. Isolation, structural characterization and glycosylation of pyridinoline. Biochem J1983; 215: 167–73
38.
FujimotoD. Evidence for natural existence of pyridinoline crosslink in collagen. Biochem Biophys Res Commun1980; 93: 948–53
39.
SakuraSFujimotoDSakamotoKMizunoAMotegiK. Photolysis of pyridinoline, a cross-linking amino acid of collagen, by ultraviolet light. Can J Biochem1982; 60: 525–9
40.
RobinsSPDuncanARiggsBL. Direct measurement of free hydroxypyridinium crosslinks of collagen in urine as new markers of bone resorption in osteoporosis. In: ChristiansenCOvergaardK, eds. Osteoporosis 1990. Copenhagen: Osteopress, ApS, 1990: 465–8
41.
EyreDRKoobTJVan NessKP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem1984; 137: 380–8
42.
WaltersCEyreDR. Collagen crosslinks in human dentin: Increasing content of hydroxypyridinium residues with age. Calcif Tissue Int1983; 35: 401–5
43.
GosselinLEMartinezDAVailasACSieckGC. Passive length-force properties of senescent diaphragm: Relationship with collagen characteristics. J Appl Physiol1994; 76: 2680–5
44.
PalokangasHKovanenVDuncanARobinsSP. Age-related changes in the concentration of hydroxypyridinium crosslinks in functionally different skeletal muscles. Matrix1992; 12: 291–6
45.
ZimmermanSDMcCormickRJVadlamudiRKThomasDP. Age and training alter collagen characteristics in fast and slow twitch rat limb muscle. J Appl Physiol1993; 75: 1670–4
46.
FujimotoDSuzukiMUchiyamaAMiyamotoSInoueT. Analysis of pyridinoline, a cross-linking compound of collagen fibers, in human urine. J Biochem1983; 94: 1133–6
47.
BlackDDuncanARobinsSP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem1988; 169: 197–203
48.
StonePJBryan-RhadfiJShawHAFranzblauC. Isolation of hydroxylysyl pyridinoline, a mature collagen crosslink from neonatal rat aorta smooth muscle cell cultures. Matrix1992; 12: 381–7
49.
JamesITPerrettDThompsonPW. Rapid assay for hard tissue collagen cross-links using isocratic ion-pair reversed-phase liquid chromatography. J Chromatogr1990; 525: 43–57
50.
ColwellARussellRGEastellR. Factors affecting the assay of urinary 3-hydroxy pyridinium cross-links of collagen as markers of bone resorption. Eur J Clin Invest1993; 23: 341–9
51.
KollerupGThamsborgGBhatiaHSorensenOH. Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography. Scand J Clin Lab Invest1992; 52: 657–62
52.
KamelSBrazierMDesmetGPicardCMennecierISebertJ. High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption. J Chromatogr1992; 574: 255–60
53.
PrattDADaniloffYDuncanARobinsSP. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem1992; 207: 168–75
54.
YoshimuraYOhnishiKHamamuraMOdaTSohdaT. Automated high-performance liquid chromatographic determination of hydroxylysylpyridinoline and lysylpyridinoline in urine using a column-switching method. J Chromatogr1993; 613: 43–9
55.
JamesITWalneAJPerrettD. Automated solid phase extraction with HPLC analysis of pyridinium crosslinks. Anal Biochem1996 (in press)
56.
LichyAMacekJAdamM. Determination of hydroxylysylpyridinoline in tissues and urine by high-performance liquid chromatography. J Chromatogr1991; 563: 153–7
57.
JamesITPerrettD. The use of capillary zone electrophoresis for the measurement of urinary pyridinoline [Abstract]. Clin Rheumatol1994; 10: 457
58.
ColwellAEastellRAl-DehaimiABigginsCRussellRGG. The measurement of 3-OH pyridinium compounds using high performance capillary electrophoresis. In: RingEFJ, ed. Current Research in Osteoporosis and Bone Mineral Measurement II: 1992, 2nd edn.London: British Institute of Radiology, 1992: 5–6
59.
EyreDR. Crosslink maturation in bone collagen. In: VeisA, ed. The Chemistry and Biology of Mineralised Connective Tissues. Amsterdam: Elsevier, 1981: 51–5
60.
KoobTJEyreDRVan NessKP. Detection and photolysis of hydroxypyridinium crosslinks in cartilage collagen in situ. Trans Ann Meet Orthopaed Res, USA1983; 28
61.
AbbiatiGRigoldiMMussiniECastiglioniC. An HPLC isocratic method for pyridinoline (HP) and deoxypyridinoline (LP) analysis: A new approach to their standard quantification. In: ChristiansenCOvergaardK, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990: 616–8
62.
JamesICrowleyCPerrettD. Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high-performance liquid chromatography. J Chromatogr1993; 612: 41–8
63.
JamesITPerrettDSkingleLGrootveldMThompsonPW. A novel pyridinoline like crosslink in human bone and urine hydrolysates. In: ChristiansenCOvergaardK, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990: 517–20
64.
SkinnerSJM. Rapid method for the purification of the elastin crosslinks, desmosine and isodesmosine. J Chromatogr1982; 229: 200–4
65.
RobinsSPMcLarenAMNicolPSeibelMJ. Pyridinium crosslink measurements in serum and synovial fluid of patients with osteoarthritis. In: KuettnerKESchleyerbachRPeyronJGHascallVC, eds. Articular Cartilage and Osteoarthritis. New York: Raven Press, 1992: 738–9
66.
AbbiatiGRigoldiMFrignaniSColomboLMussiniE. Determination of pyridinium crosslinks in plasma and serum by high-performance liquid chromatography. J Chromatogr1994; 656: 303–10
67.
WalneAJJamesITPerrettD. Baseline data for serum pyridinium crosslinks in a normal population [Abstract]. Arthritis Rheum1995; 38: S356
68.
RobinsSP. An enzyme-linked immunoassay for the collagen cross-link pyridinoline. Biochem J1982; 207: 617–20
69.
RobinsSPStewartPAstburyCBirdHA. Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease. Ann Rheum Dis1986; 45: 969–73
70.
OhishiTTakahashiMKushidaKHoriuchiKIshigakiSInoueT. Quantitative analyses of urinary pyridinoline and deoxypyridinoline excretion in patients with hyperthyroidism. Endocr Res1992; 18: 281–90
71.
Gunja-SmithZ. An enzyme-linked immunosorbent assay to quantitate the elastin crosslink desmosine in tissue and urine samples. Anal Biochem1985; 147: 258–64
72.
CalabresiELasagniLFranceschelliFBartoliniLSerioMBrandiML. Use of an internal standard to measure pyridinoline and deoxypyridinoline in urine [Letter]. Clin Chem1994; 40: 336–7
73.
RobinsSPSteadDADuncanA. Precautions in using an internal standard to measure pyridinoline and deoxypyridinoline in urine. Clin Chem1994; 40: 2322–3
74.
CalabresiELasagniLFranceschelliFBartoliniLSerioMBrandiML. Precautions in using an internal standard to measure pyridinoline and deoxypyridinoline in urine. Clin Chem1994; 40: 2323
75.
RisteliJElomaaINiemiSNovamoARisteliL. Radioimmunoassay for the pyridinoline cross-linked carboxy terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem1993; 39: 635–40
76.
BondeMQvistPFledeliusCRiisBJChristiansenC. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem1994; 40: 2022–3
77.
GarneroPGineytsERiouJPDelmasPD. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab1994; 79: 780–5
78.
HansonDAWeisMABollenAMMaslanSLSingerFREyreDR. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res1992; 7: 1251–8
79.
FoxPStampTCB. Immunoassay of collagen crosslinks in acidified urine. Ann Clin Biochem1995; 32: 326–8
80.
RobinsSPWoitgeHHesleyRJuJSeyedinSSeibelMJ. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res1994; 9: 1643–9
81.
ChenSYKlineSLindseyKSeyedinSHesleyR. An automated chemiluminescent assay for deoxypyridinoline: A urinary marker for bone resorption [Abstract]. J Bone Miner Res1994; 9: A376
82.
van HoekMJCMartensMFWCWalchliRGamseRRosmalenFMA. A novel polyclonal antibody against deoxypyridinoline to be used in a radioimmunoassay [Abstract]. Second Workshop on Bisphosphonates: From the Laboratory to the Patient, Davos, April 14–16 1994. Geneva: Nichols Institute Diagnostics, 1994
83.
UrenaPFerreiraAKungVTMorieuxCSimonPAngKS. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in haemodialysis patients. J Bone Miner Res1995; 10: 932–9
84.
KungVTGomezBLungardRSeyedinSClarkBRiggsL. An immunoassay for the measurement of free pyridinoline in serum: A marker of bone resorption [Abstract]. J Bone Miner Res1993; 8: S151
85.
ElomaaIVirkkunenPRisteliLRisteliJ. Serum concentration of the crosslinked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer1992; 66: 337–41
86.
Metra Biosystems.Pyd/Dpd HPLC Calibrator: Assay Literature. Mountain View, CA, USA: Metra Biosystems, 1994: 2
87.
EastellRSimmonsPSColwellAAssiriAMBurrittMFRussellRG. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: Effects of growth and ageing. Clin Sci1992; 83: 375–82
88.
McLarenAMIsdaleAHWhitingPHBirdHARobinsSP. Physiological variations in the urinary excretion of pyridinium crosslinks of collagen. Br J Rheumat1993; 32: 307–12
89.
AbbiatiGBartucciFLongoniAFincatoGGalimbertiSRigoldiM. Monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers: Sample relationships between 24-h and fasting early morning urine concentrations. Bone Miner1993; 21: 9–19
90.
GerritsMIThijssenJHHHermanJMvan RijnJM. Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability. Clin Chem1995; 41: 571–4
91.
WalneAJJamesITPerrettD. The stability of pyridinium crosslinks in urine and serum. Clin Chim Acta1995; 240: 95–7
92.
SeibelMJWoitgeHScheidtnaveGLeidigbrucknerGDuncanANicolP. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: Results of a pilot study. J Bone Miner Res1994; 9: 1433–40
93.
ScottPJHurleyPJ. Demonstration of individual variation in constancy of 24 hour urinary creatinine excretion. Clin Chim Acta1968; 21: 411–14
94.
AlessioLBerlinADell'OrtoAToffolettoFGhezziI. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Hlth1985; 55: 99–106
95.
WebsterJGarrowJS. Creatinine excretion over 24 hours as a measure of body composition or of completeness of urine collection. Human Nutr-Clin Nutr1985; 39: 101–6
96.
BlumenkrantzNAsboe-HansenG. Urinary creatinine is unsuitable as reference value for collagen metabolite output. Clin Biochem1977; 10: 109–10
97.
HeymsfieldSBArteagaCMcManusCSmithJMoffittS. Measurement of muscle mass in humans: Validity of the 24-hour urinary creatinine method. Am J Clin Nutr1983; 37: 478–94
EastellRAssiriAMABlumsohnAHannonRAPeelNFAColwellA. The need for several biochemical markers to evaluate bone turnover in older women [Abstract]. J Bone Miner Res1994; 6: 73
100.
SchlemmerAJohansenJSPedersenSAJorgensenJOHassagerCChristiansenC. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol1991; 35: 471–6
101.
BodyJJDelmasPD. Urinary pyridinium crosslinks as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab1992; 74: 471–5
102.
LiptonADemersLDaniloffYCurleyEHamiltonCHarveyH. Increased urinary excretion of pyridinium cross-links in cancer patients. Clin Chem1993; 39: 614–8
103.
SpectorTDJamesITHallGMThompsonPWPerrettDHartDJ. Increased levels of urinary collagen crosslinks in females with rheumatoid arthritis. Clin Rheumatol1993; 12: 240–4
104.
SeibelMJCosmanFShenVGordonSDempsterDWRatcliffeA. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res1993; 8: 881–9
105.
PecherstorferMZimmerrothISchillingTWoitgeHWSchmidtHBaumgartnerG. The diagnostic value of urinary pyridinium crosslinks of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. J Clin Endocrinol Metab1995; 80: 97–103
106.
SeibelMJDuncanARobinsSP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol1989; 16: 964–70
107.
OhishiTKushidaKTakahashiMKawanaKYagiKKawakamiK. Urinary bone resorption markers in patients with metabolic bone disorders. Bone1994; 15: 15–20
108.
WishartJMNeedAGHorowitzMMorrisHANordinBEC. Effect of age on bone density and bone turnover in men. Clin Endocrinol1995; 42: 141–6
109.
DelmasPDGineytsEBertholinAGarneroPMarchandF. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Min Res1993; 8: 643–8
110.
HessBCasezJPTakkinenRAckermannDJaegerP. Relative hypoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers—impact of nutrition. Am J Nephrol1993; 13: 18–26
111.
HopperJLSeemanE. The bone density of female twins discordant for tobacco use. N Engl J Med1994; 330: 387–92
112.
Lieuw-A-FaMSierraRISpeckerBL. Carboxy-terminal propeptide of human type I collagen and pyridinium crosslinks as markers of bone growth in infants 1 to 18 months of age. J Bone Miner Res1995; 10: 849–53
113.
BlumsohnAHannonRAWrateRBartonJAl-DehaimiAWColwellA. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol1994; 40: 663–70
114.
OhishiTTakahashiMKawanaKAoshimaHHoshinoHHoriuchiK. Age-related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects. Clin Invest Med1993; 16: 319–25
115.
BollenAMEyreDR. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone1994; 15: 31–4
116.
KawanaKKushidaKTakahashiMOhishiTDendaMYamazakiK. The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. Calcif Tissue Int1994; 55: 420–5
117.
UebelhartDSchlemmerAJohansenJSGineytsEChristiansenCDelmasPD. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab1991; 72: 367–73
118.
HassagerCColwellAAssiriAMEastellRRussellRGChristiansenC. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: A longitudinal and cross-sectional study. Clin Endocrinol1992; 37: 45–50
119.
SchlemmerAHassagerCRisteliJRisteliLJensenSBChristiansenC. Possible variation in bone resorption during the normal menstrual cycle. Acta Endocrinol1993; 129: 388–92
120.
SchlemmerAHassagerCJensenSBChristiansenC. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab1992; 74: 476–80
121.
EastellRCalvoMSBurrittMFOffordKPRussellRGRiggsBL. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab1992; 74: 487–94
122.
FincatoGBartucciFRigoldiMAbbiatiGColomboMBartoliniO. Urinary excretion of pyridinoline and deoxypyridinoline: Circadian rhythm in healthy premenopausal women. J Interdiscipl Cycle Res1993; 24: 72–8
123.
SchlemmerAHassagerCPedersenBJChristiansenC. Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J Bone Miner Res1994; 9: 1883–8
124.
PaganiPPanteghiniM. Diurnal rhythm in urinary excretion of pyridinium crosslinks. Clin Chem1994; 40: 952–3
125.
SeyedinSMKungVTDaniloffYNHesleyRPGomezBNielsenLA. Immunoassay for urinary pyridinoline: The new marker of bone resorption. J Bone Miner Res1993; 8: 635–41
126.
GertzBJShaoPHansonDAQuanHHarrisSTGenantHK. Monitoring bone resorption in early postmenopausal women by an immunoassay for crosslinked collagen peptides in urine. J Bone Miner Res1994; 9: 135–42
127.
BrancaFRobinsSPFerro-LuzziAGoldenMH. Bone turnover in malnourished children. Lancet1992; 340: 1493–6
128.
McLarenAMHordonLDBirdHARobinsSP. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis1992; 51: 648–51
129.
RobinsSPSiebelMJMcLarenAM. Collagen markers in urine in human arthritis. In: MaroudasAKuettnerK, eds. Methods In Cartilage Research. London: Academic Press, 1990: 348–51
130.
IsdaleAHelliwellPS. Athletes and osteoarthritis—Is there any relationship?Br J Rheumatol1991; 30: 67–8
131.
HetlandMLHaarboJChristiansenC. Low bone mass and high bone turnover in male long distance runners. J Clin Endocrinol Metab1993; 77: 770–5
132.
HatoriMHasegawaAAdachiHShinozakiAHayashiROkanoH. The effects of walking at the anaerobic threshold level on vertebral bone loss in post menopausal women. Calcif Tissue Int1993; 52: 411–14
133.
MorrisHAWishartJMHorowitzMNeedAGNordinBEC. The reproducibility of bone related biochemical variables in post menopausal women. Ann Clin Biochem1990; 27: 562–8
134.
BlumsohnAHannonRAAl-DehaimiAWEastellR. Short term intraindividual variability of markers of bone turnover in healthy adults [Abstract]. J Bone Miner Res1994; 9: 132
135.
BondeMQvistPFledeliusCRiisBJChristiansenC. Applications of an enzyme immunoassay for a new marker of bone resorption (crosslaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab1995; 80: 864–8
136.
FledeliusCRiisBJOvergaardKChristiansenC. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int1994; 54: 381–4
137.
EriksenEFCharlesPMelsenFMoselkildeLRisteliLRisteliJ. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res1993; 8: 127–32
138.
HassagerCJensenLTPodenphantJThomsenKChristiansenC. The carboxy-terminal pyridinoline crosslinked telopeptide of type I collagen in serum as a marker of bone resorption. The effect of nandrolone decanoate and hormone replacement therapy. Calcif Tissue Int1994; 54: 30–3
139.
ValimakiMJTahtelaRJonesJDPetersonJMRiggsBL. Bone resorption in healthy and osteoporotic postmenopausal women: Comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links. Eur J Endocrinol1994; 131: 258–62
140.
GarneroPShihWCJGineytsEKarpfDBDelmasPD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab1994; 79: 1693–700
141.
BlumsohnAHerringtonKHannonRAShaoPEyreDREastellR. The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab1994; 79: 730–5
142.
RosenHNDresner-PollakRMosesACRosenblattMZeindAJClemensJD. Specificity of urinary excretion of crosslinked N-telopeptides of type I collagen as a marker of bone collagen turnover. Calcif Tissue Int1994; 54: 26–9
143.
GarneroPShihWJGineytsEKarpfDBDelmasPD. Assessment of 8 markers of bone turnover in post menopausal (PMP) osteoporotic women treated with alendronate (ALN). [Abstract]. Second Workshop on Bisphosphonates: From the Laboratory to the Patient, Davos, April 14–16 1994. Geneva: Nichols Institute Diagnostics, 1994
144.
AlexandersenPSchlemmerARiisBJChristiansenC. Circadian variation in crosslaps—A new marker of type I collagen degeneration [Abstract]. J Bone Miner Res1994; 9: S190
145.
ChristiansenCRiisBJRodbroP. Prediction of rapid bone loss in postmenopausal women. Lancet1987; i: 1605–8
146.
OvergaardKRiisBJBondeMChristiansenC. A new biochemical marker for the determination of optimum treatment regimen of nasal calcitonin and the effect on fracture rate [Abstract]. J Bone Miner Res1994; 9: S403